CT
Corcept Therapeutics
Resolving
Resolving brand mentions across new media
Corcept Therapeutics
Arcmira media summary
Arcmira tracks where Corcept Therapeutics is discussed across indexed YouTube videos, transcripts, channels, and related entities.
Pharmaceutical firm whose shares rose 15% following positive Phase 3 trial results.
Biotech firm whose stock fell 50% after FDA drug rejection.
Biotech company whose stock fell 50% after a drug rejection.
3
Mentions
270
Views
“Pharmaceutical firm whose shares rose 15% following positive Phase 3 trial results.”
“Biotech firm whose stock fell 50% after FDA drug rejection.”
“Biotech company whose stock fell 50% after a drug rejection.”
Arcmira tracks 3 indexed media appearances or mentions for Corcept Therapeutics, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "Corcept Therapeutic Soars, Abbott Labs Sinks, Arista Networks Jumps on AI Spending | Stock Movers" with transcript-derived context and links when available.
Corcept Therapeutics is connected to Bitcoin, AI spending in Arcmira's media graph.